Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

116.60
+0.20700.18%
Post-market: 116.600.0032+0.00%19:30 EDT
Volume:10K
Turnover:1.13M
Market Cap:101.44M
PE:- -
High:116.74
Open:116.27
Low:113.31
Close:116.39
52wk High:126.40
52wk Low:55.34
Shares:870.00K
Float Shares:870.00K
Volume Ratio:0.88
T/O Rate:1.13%
Dividend:0.33
Dividend Rate:0.28%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 12

Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad

THOMSON REUTERS
·
Aug 12

MacroGenics Rises on $10 Million Milestone Payment from Gilead

Reuters
·
Aug 12

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 12

MacroGenics Raih Pembayaran USD 10 Juta Usai Gilead Ambil Lisensi Program Bispesifik Praklinis

Reuters
·
Aug 12

MacroGenics - Remains Eligible to Receive up to Approximately $1.6 Bln in Additional Development

THOMSON REUTERS
·
Aug 12

Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Tango Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 11

Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals Incorporated : Bofa Global Research Adds Stock to Its US 1 List

THOMSON REUTERS
·
Aug 11

Vertex Pharmaceuticals added to ‘US 1 List’ at BofA

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $633 from $610

THOMSON REUTERS
·
Aug 11

Lakefront Biotherapeutics Boosts Immunology Push With Ouro Deal and Strong Cash Outlook

TIPRANKS
·
Aug 11

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Lakefront Biotherapeutics H1 FY26 Net Sales Drop 87% to EUR 18.6 Million; Operating Loss Narrows 54% to EUR 107.2 Million

Reuters
·
Aug 11

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

MT Newswires Live
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10